2016•New England Journal of MedicineOpen access

Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea

Helen Fifer, Usha Natarajan, Lucy C. Jones, Sarah Alexander, Gwenda Hughes, Daniel Golparian, Magnus Unemo

Open full text 344 citations

Abstract

Increasing antibacterial resistance in Neisseria gonorrhoeae is threatening the success of routine treatment. This letter describes the clinical failure of ceftriaxone and azithromycin in a patient with gonorrhea.

Open-access reader

About this research paper

What this paper is about

Increasing antibacterial resistance in Neisseria gonorrhoeae is threatening the success of routine treatment. This letter describes the clinical failure of ceftriaxone and azithromycin in a patient with gonorrhea.

Why it matters

OpenAlex reports 344 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Increasing antibacterial resistance in Neisseria gonorrhoeae is threatening the success of routine treatment. This letter describes the clinical failure of ceftriaxone and azithromycin in a patient with gonorrhea.

Key concepts: Medicine, Gonorrhea, Antimicrobial, Dual (grammatical number), Anti-Infective Agents, Intensive care medicine, Internal medicine, Microbiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea — Research Paper | ScholarLens